GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Pharmaceutical Intermediates Market, By Intermediate Type (Bulk Intermediate, Chemical Intermediate), By Application (Anti-Infective Drugs, Analgesics, Antidiabetic Drugs, Cardiovascular Drugs, Antimicrobial Drugs, Anti-inflammatory Drugs, Others), By End User (Biopharmaceutical Companies, CMO, CRO, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Mar 2024
Code : CMI6740
Pages :165
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Global Pharmaceutical Intermediates Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Rising Research and Development Activities by Big Pharma

Another key driver for the pharmaceutical intermediates market has been the increasing research and development investments and activities undertaken by large pharmaceutical corporations. Despite facing numerous challenges, big pharma companies have continued devoting greater resources towards new drug development programs in therapeutically important areas. The discovery and development of new molecular entities requires the extensive synthesis, screening, and testing of various intermediates during the chemical process. Any candidate molecules demonstrating efficacy and safety are then subjected to further optimization and scale-up involving multifarious intermediates. The entire cycle from target identification to commercialization entails synthesizing multitudes of intermediates. Therefore, as big pharma’s R&D budgets and pipelines expand, they translate into higher outsourcing of intermediate manufacturing responsibilities.

Key Players Insights